Pick a buyer type to preview their entitlements
Pharma / Biotech
No off-label promotion
Drug Mfgr / PBM
Approved indications only
Insurance / Payor
No individual underwriting (ACA §1182)
Clinical Trial / CRO
IRB required · protocol-limited
Data Aggregator
RESALE PROHIBITED
Health IT / EHR
Interoperability use only
ACO / Care Mgmt
Covered entity / BAA required
Academic Research
IRB · no commercial gain
Employer Plan
OWN MEMBERS ONLY (GINA/ADA)
Government
Aggregate only · FOIA risk
AI / Analytics
Re-identification audit required
Pharma / Biotech
Pharmaceutical and biotech buyers researching drug efficacy, post-market surveillance, real-world evidence cohorts.
Special rules for this buyer type: No data may be used for off-label promotion. Data limited to therapeutic class relevant to approved indications. All purchases logged to Confidential Ledger; downstream use audited.
7 data categories — entitlements for PHARMA
⚖️
Hard blocks — not consent-overridable
Substance Use Disorder records (42 CFR Part 2) are NEVER sold to ANY buyer type. Mental Health (Texas §611) and Genetic data (GINA) have hard rules per buyer type. Identifiable patient data is NEVER sold (HIPAA Safe Harbor §164.514) — only de-identified cohorts with minimum cohort sizes (10–1,000 patients depending on category). Re-identification attempts are logged and grounds for buyer ban + legal action.